Capstone Reports Q1 2026 Results: Revenue Up 60%, Gross Profit Up 124%, Best Q1 Gross Margin in Four Years

Go back to Capstone Reports Q1 2026 Results: Revenue Up 60%, Gross Profit Up 124%, Best Q1 Gross Margin in Four Years
Capstone Therapeutics Corp (NASDAQ: CAPS) Delayed: 0.29 +0.01 (3.57%)
Previous Close $0.28    52 Week High $0.15 
Open $0.29    52 Week Low $0.04 
Day High $0.29    P/E N/A 
Day Low $0.28    EPS $-0.27 
Volume 32,369